Clinical trial
Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects…
NCT00314652 · Purdue Pharma LP, Industry · Completed
Key facts
| NCT number | NCT00314652 |
|---|---|
| Title | Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain. |
| Official title | A Double-Blind Placebo-Controlled Study of Buprenorphine Transdermal System (BTDS) in Patients With Osteoarthritis of the Hip or Knee |
| Lead sponsor | Purdue Pharma LP, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoarthritis |
| Intervention type | Drug |
| Interventions | Buprenorphine transdermal delivery system |
| Enrollment | 260 |
| Start date | Jun 1, 1999 |
| Completion | Oct 1, 1999 |
| First posted | Apr 14, 2006 |
| Last update posted | May 3, 2006 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: